ALK and anaplastic large cell lymphoma: The 2016 WHO classification identifies four separate biological entities: primary systemic ALK-positive ALCL (ALK-positive ALCL), primary systemic ALK-negative ALCL, primary cutaneous ALCL and breast implant-associated ALCL.